CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.
- DOI
- 10.1073/pnas.2115116118
- Published
- 2021-11-01
- Container
- Proc Natl Acad Sci U S A
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2115116118,
title = {CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.},
author = {Naert T and Tulkens D and Van Nieuwenhuysen T and Przybyl J and Demuynck S and van de Rijn M and Al-Jazrawe M and Alman BA and Coucke PJ and De Leeneer K and Vanhove C and Savvides SN and Creytens D and Vleminckx K.},
year = {2021},
journal = {Proc Natl Acad Sci U S A},
doi = {10.1073/pnas.2115116118},
url = {https://doi.org/10.1073/pnas.2115116118}
}RIS
TY - JOUR TI - CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping. AU - Naert T AU - Tulkens D AU - Van Nieuwenhuysen T AU - Przybyl J AU - Demuynck S AU - van de Rijn M AU - Al-Jazrawe M AU - Alman BA AU - Coucke PJ AU - De Leeneer K AU - Vanhove C AU - Savvides SN AU - Creytens D AU - Vleminckx K. PY - 2021 JO - Proc Natl Acad Sci U S A DO - 10.1073/pnas.2115116118 UR - https://doi.org/10.1073/pnas.2115116118 ER -
APA
T, N., D, T., T, V. N., J, P., S, D., M, V. D. R., M, A., BA, A., PJ, C., K, D. L., C, V., SN, S., D, C., & K., V. (2021). CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.2115116118
Source records
- europe-pmc · retrieved 2026-09-25T13:10:49.397Z